Our study also confirmed that the high expression of ALDOA promoted the progress of ICC, and Itaconate can directly inhibit the glycolysis level of ICC tumor cells and thus affect tumor progression. This evidence concerns the gene ALDOA and intrahepatic cholangiocarcinoma.